3,4-Cyclobutenopyridine | 56911-27-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 3,4-Cyclobutenopyridine
• 英文别名: 3-azabicyclo[4.2.0]octa-1(6),2,4-triene
• CAS: 56911-27-4
• 化学式: C₇H₇N
• 分子量: 105.14
• InChiKey: ZUWBZVZRPOWTJR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.3
• 重原子数：
  8
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  12.9
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  3,4-Cyclobutenopyridine 生成 3-aza-bicyclo[4.2.0]octane
  参考文献：
  名称：

  THUMMEL R. P.; KOHLI D. K., D1J. ORG. CHEM., 1978, 43, NO 25, 4882-4884

  摘要：

  DOI：
• 作为产物：
  描述：

  2-Chloro-3-azabicyclo[4.2.0]octa-1(6),2,4-triene 以55%的产率得到
  参考文献：
  名称：

  KANEKO, CHIKARA;NAITO, TOSHIHIKO;MOMOSE, YU;FUJII, HARUE;NAKAYAMA, NAYOMI+, CHEM. AND PHARM. BULL., 1982, 30, N 2, 519-525

  摘要：

  DOI：

文献信息

• [EN] AZETIDIN-3-YLMETHANOL DERIVATIVES AS CCR6 RECEPTOR MODULATORS<br/>[FR] DÉRIVÉS D'AZÉTIDIN-3-YLMÉTHANOL EN TANT QUE MODULATEURS DU RÉCEPTEUR CCR6
  申请人：IDORSIA PHARMACEUTICALS LTD

  公开号：WO2021219849A1

  公开（公告）日：2021-11-04

  The present invention relates to compounds of Formula (I), their synthesis and use as CCR6 receptor modulators for the treatment or prevention of various diseases, conditions or disorders.

  本发明涉及式(I)化合物，其合成以及作为CCR6受体调节剂用于治疗或预防各种疾病、状况或障碍。
• POLYMERIC CHARGE TRANSFER LAYER AND ORGANIC ELECTRONIC DEVICE CONTAINING SAME
  申请人：Dow Global Technologies LLC

  公开号：US20180212180A1

  公开（公告）日：2018-07-26

  The present invention provides a polymeric charge transfer layer composition comprising a polymer comprising, as polymerized units, at least one Monomer A and at least one Monomer B. It further provides an organic light emitting device and an organic electronic device comprising the polymeric charge transfer layer.

  本发明提供了一种聚合物电荷转移层组成物，其包括聚合物，该聚合物包括至少一个单体A和至少一个单体B作为聚合单元。本发明还提供了一种有机发光器件和有机电子器件，其中包括聚合物电荷转移层。
• RIEMANN J. M.; TRAHANOVSKY W. S., TETRAHEDRON LETT. <TELE-AY>, 1977, NO 22, 1867-1870
  作者：RIEMANN J. M.、 TRAHANOVSKY W. S.

  DOI：——

  日期：——
• [EN] TRICYCLIC STEROID HORMONE NUCLEAR RECEPTOR MODULATORS<br/>[FR] MODULATEURS TRICYCLIQUES DU RECEPTEUR NUCLEAIRE DES HORMONES STEROIDIENNES
  申请人：LILLY CO ELI

  公开号：WO2004052847A2

  公开（公告）日：2004-06-24

  The present invention relates to methods of treating pathological disorders susceptible to steroid hormone nuclear receptor modulation comprising administering to a patient in need thereof an effective amount of a compound of the formula (I): or a pharmaceutically acceptable salt thereof. In addition, the present invention provides novel pharmaceutical compounds of Formula (I), including the pharmaceutically acceptable salts thereof, as well as pharmaceutical compositions which comprise as an active ingredient a compound of Formula (I).
• [EN] POLYMERIC CHARGE TRANSFER LAYER AND ORGANIC ELECTRONIC DEVICE CONTAINING SAME<br/>[FR] COUCHE DE TRANSFERT DE CHARGE POLYMÈRE ET DISPOSITIF ÉLECTRONIQUE ORGANIQUE LA CONTENANT
  申请人：DOW GLOBAL TECHNOLOGIES LLC

  公开号：WO2017031622A1

  公开（公告）日：2017-03-02

  Provided is a polymeric charge transfer layer composition comprising a polymer comprising, as polymerized units, at least one Monomer A and at least one Monomer B. Further provided are an organic light emitting device and an organic electronic device comprising the polymeric charge transfer layer.